The promoter group holds 57.68 percent stake while the bloc of private equity investors holds 31.52 percent in SRL Diagnostics. The investors include the likes of NY Jacob Ballas and the World Bank's development finance arm IFC
The company, which specialises in construction of highways, bridges, flyovers and airport runways, is making a public issue of up to 12,921,708 equity shares of face value of Rs 10 each including a share premium per equity share.
Vishal Bali, group CEO,Fortis Healthcare explains to CNBC-TV18 that the private funding from IFC and Jacob Ballas has resulted in holding company Super Religare Laboratories turning debt-free. He added that though the company was keen on inorganic growth, the current priority is consolidation
CNBC-TV18's Harish Rao reports, quoting sources, that PE (private equity) fund Jacob Ballas has closed a deal to buy stake in Karaikal Port, a 100% subsidiary of Marg Limited.
PE fund Jacob Ballas will buy stake in Margs' Karaikal Port, reports CNBC-TV18.